The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

Z. Safipour, R. van Der Zanden, J. van den Bergh, P. Janssen, P. Vestergaard, F. de Vries, J.H.M. Driessen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Number of pages10
JournalOsteoporosis International
Publication statusE-pub ahead of print - 3 Oct 2021


  • Glucocorticoids
  • Fracture
  • Bone
  • Myasthenia gravis
  • Case-control study

Cite this